Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab
Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences…
Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences…